Coronary stent graft for hypertrophic obstructive cardiomyopathy combined with coronary artery disease

Journal of the Formosan Medical Association

Volumn 102, Issue 8, 2003, Pages 574-577

  Huang, Chi Hung ^a   Chen, I Chung ^a   Chiou, Herng Cheng ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiomyopathy, hypertrophic; Case report; Coronary atherosclerosis; Myocardial disease, surgery; Stents

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; CLOPIDOGREL; DILTIAZEM;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; SYMPTOMATOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ARTERIOSCLEROSIS; HUMANS; MALE; TREATMENT OUTCOME;

EID: 0347527235     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gruentzig AR, Senning A, Siegenthaler WE: Non-operative dilatation of coronary artery stenosis. N Engl J Med 1979;301: 61-8.
2. Sigwart U: Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 1995:346:211-4.
3. Knight C, Kurbaan AS, Seggewiss H, et al: Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-81.
4. Nagueh SF, Ommen SR, Lakkis NM, et al: Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-6.
5. Qin JX, Shiota T, Lever HM, et al: Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
6. Seggewiss H, Faber L, Meyners W, et al: Simultaneous percutaneous treatment in hypertrophic obstructive cardiomyopathy and coronary artery disease: a case report. Cathet Cardiovasc Diagn 1998;44:65-9.
7. Wigle ED, Rakowski H, Kimball BP, et al: Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92:1680-92.
8. Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathies, part I. Circulation 2001;104:2113-6.
9. Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathies, part II. Circulation 2001;104:2249-52.
10. McCully RB, Nishimura RA, Hayes DL, et al: Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94:467-71.
11. Robbins RC, Stinson EB, Daily PO: Long-term results of left ventricular myotomy and myectomy for hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:586-94.
12. Jeanrenaud X, Goy JJ, Kappenberger L: Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339:1319-23.
13. Nishimura RA, Trusty JM, Hayes DL: Dual chamber pacing for hypertrophic obstructive cardiomyopathy: a randomized, double-blind, crossover study. J Am Coll Cardiol 1997;27:435-41.
14. Vanderheyden M, Willaert W, Claessens P: Nonalcoholic percutaneous transluminal septal ablation for hypertrophic cardiomyopathy with obstruction. Am J Cardiol 2002;89: 361-2.